Product Details
Synonyms
IL36G, IL-1RP2, IL-1 epsilon, IL-1F9, IL-1H1, IL1E, IL1F9, IL1H1, IL1RP2
Source
Human IL-36 gamma Protein, Tag Free (IL9-H5115) is expressed from E. coli cells. It contains AA Ser 18 - Asp 169 (Accession # Q9NZH8-1).
Predicted N-terminus: Ser 18
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries no "tag".
The protein has a calculated MW of 17.0 kDa. The protein migrates as 15-16 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Kunden haben auch angesehen
Data Display
SDS-PAGE

Human IL-36 gamma Protein, Tag Free on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS

The purity of Human IL-36 gamma Protein, Tag Free (Cat. No. IL9-H5115) is more than 90% and the molecular weight of this protein is around 15-25 kDa verified by SEC-MALS.
Report
User Reviews Publish Comment

Background Introduction
Frontier Progress
- English Name:
Interleukin-36 gamma
- Category:
- Listed Drugs Count:
0 Details
- Clinical Drugs Count:
1 Details
- Highest R&D Stage:
Phase 1 Clinical



















